Pure Global

SAA Rapid Quantitative Test - India CDSCO Medical Device Registration

SAA Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_6b6e0fb0d438481d961ddc5a52b538f8_3d568b6416aed37082618e1274abcfcb. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
SAA Rapid Quantitative Test
UID: IMP/IVD/2022/000074_6b6e0fb0d438481d961ddc5a52b538f8_3d568b6416aed37082618e1274abcfcb

Brand Name

Glycated Hemoglobin

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Serum Amyloid A (Glycated Hemoglobin) Rapid Quantitative Test along with Aehealth Fluorescence Immunoassay Analyzer (Glycated Hemoglobin) is intended for in vitro quantitative determination of SAA in human whole blood, serum or plasma. It is mainly as a non-specific inflammation indicator

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing